FDA approves breakthrough cancer drug months ahead of schedule: ‘Unprecedented results’
General Oregon
Archived
•
August 27, 2026
•
The FDA approved the medication more than six months ahead of schedule after trials showed it nearly doubled median survival to 13.2 months versus 6.7 months with chemotherapy.
Source: OregonLive OR | https://www.oregonlive.com/arc/outboundfeeds/rss/?outputType=xml - Read Original
"Adventure is where you chose to go."
"Camping the Easyway"
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
Sponsored
